42 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
Rank Status Study
21 Recruiting Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Male Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Dietary Supplement: omega-3 fatty acid;   Other: placebo;   Other: laboratory biomarker analysis
22 Recruiting Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Ductal Breast Carcinoma In Situ;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Invasive Breast Carcinoma;   Multicentric Breast Carcinoma;   Multifocal Breast Carcinoma;   Synchronous Bilateral Breast Carcinoma
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Drug: Systemic Chemotherapy;   Drug: Tamoxifen Citrate
23 Not yet recruiting Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Conditions: Breast Cancer;   Ductal Carcinoma;   Invasive Breast Carcinoma;   Invasive Ductal Breast Carcinoma
Interventions: Biological: Talimogene laherparepvec;   Drug: Paclitaxel
24 Recruiting Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1
Condition: Invasive Ductal Breast Carcinoma
Interventions: Drug: Carboplatin;   Drug: Abraxane;   Drug: MPDL3280A;   Procedure: Surgery;   Drug: Anthra
25 Recruiting Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Recurrent Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: fulvestrant;   Drug: anastrozole
26 Recruiting BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Invasive Ductal Breast Carcinoma;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: PI3K inhibitor BYL719;   Drug: letrozole;   Other: laboratory biomarker analysis;   Other: pharmacological studies
27 Unknown  Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ
Condition: Breast Cancer
Interventions: Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: laboratory biomarker analysis
28 Recruiting Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers
Condition: Breast Cancer
Intervention: Procedure: contrast-enhanced magnetic resonance imaging
29 Unknown  "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"
Conditions: Infiltrating Duct and Lobular Carcinoma In Situ;   Invasive Lobular Breast Carcinoma;   Inflammatory Breast Carcinoma
Intervention: Drug: Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab
30 Unknown  The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer
Condition: Mammary Ductal Carcinoma
Intervention:
31 Recruiting Intraoperative Boost Radiotherapy With Electrons (IOERT) Followed By Hypofractionated Whole-Breast Irradiation (WBRT)
Condition: Invasive Lobular and Ductal Carcinoma
Interventions: Radiation: Hypofractionated Whole Breast Radiation Therapy;   Radiation: Intraoperative Electron Radiation Therapy
32 Unknown  Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
Condition: Carcinoma, Invasive Ductal, Breast
Interventions: Drug: Vinorelbine plus Capecitabine for 6 cycles, followed by Capecitabine;   Drug: Docetaxel plus Capecitabine for 6 cycles, followed by Capecitabine
33 Recruiting Radiation Therapy in Treating Women With Early Stage Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: External beam boost;   Radiation: whole breast irradiation
34 Unknown  Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
35 Unknown  Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer
Conditions: Breast Cancer;   Pain;   Perioperative/Postoperative Complications
Intervention: Procedure: therapeutic conventional surgery
36 Unknown  Radiation Therapy in Treating Women With Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery
Condition: Breast Cancer
Intervention: Radiation: radiation therapy
37 Recruiting Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: therapeutic conventional surgery;   Radiation: whole breast irradiation
38 Unknown  Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers
Condition: Breast Cancer
Interventions: Genetic: DNA analysis;   Genetic: polymorphism analysis;   Genetic: protein analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Other: survey administration
39 Unknown  Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ
Condition: Breast Cancer
Interventions: Radiation: partial breast irradiation;   Radiation: whole breast irradiation
40 Unknown  Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Condition: Breast Cancer
Interventions: Drug: pegylated liposomal doxorubicin hydrochloride;   Genetic: DNA methylation analysis;   Genetic: TdT-mediated dUTP nick end labeling assay;   Genetic: fluorescence in situ hybridization;   Genetic: loss of heterozygosity analysis;   Genetic: polymerase chain reaction;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: breast duct lavage;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years